These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8393397)

  • 1. Detection and sequencing of p53 gene mutations in bronchial biopsy samples in patients with lung cancer.
    Mitsudomi T; Lam S; Shirakusa T; Gazdar AF
    Chest; 1993 Aug; 104(2):362-5. PubMed ID: 8393397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of p53 gene mutation in bronchial biopsy samples from lung cancer patients with polymerase chain reaction-single strand conformation polymorphism-silver staining method].
    Zhu Z; Li L; Zhu Y
    Zhonghua Nei Ke Za Zhi; 1996 Nov; 35(11):738-40. PubMed ID: 9592339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
    Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM
    Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of p53 gene mutations in cytopathology and biopsy specimens from patients with lung cancer.
    Murakami I; Fujiwara Y; Yamaoka N; Hiyama K; Ishioka S; Yamakido M
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1117-23. PubMed ID: 8887616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 gene mutations in non-small cell lung cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis.
    Zhao Y; Wu D; Xiang X; Zhang B; Zhou N; Hu Y
    Chin Med Sci J; 1999 Sep; 14(3):134-7. PubMed ID: 12903811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
    Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between p53 mutation and clinicopathological features of non-small cell lung cancer.
    Guang SG; Ogura T; Sekine I; Yokozaki M; Esumi H; Kodama T; Nagai K
    Jpn J Clin Oncol; 1997 Aug; 27(4):211-5. PubMed ID: 9379505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of mutation types of p53 gene and possible carcinogenic factors in lung cancer].
    Gao ZQ; Gao Z; Zhang X
    Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Mar; 31(2):88-91. PubMed ID: 9812619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and sequencing of p53 gene mutations in bronchial biopsy samples in patients with lung cancer.
    Zalcman G; Trédaniel J; Hirsch A; Lubin R; Soussi T
    Chest; 1994 Oct; 106(4):1309-10. PubMed ID: 7924532
    [No Abstract]   [Full Text] [Related]  

  • 10. [The clinical significance of detection of p53 gene mutation in patients with lung cancer].
    Chen Y; Cai Y; Liu L; Wang A; Wang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Nov; 25(11):667-9. PubMed ID: 12490121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients.
    Murata M; Tagawa M; Kimura H; Kakisawa K; Shirasawa H; Fujisawa T
    Int J Oncol; 1998 Mar; 12(3):577-81. PubMed ID: 9472095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
    Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
    J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
    Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis.
    Mills NE; Fishman CL; Scholes J; Anderson SE; Rom WN; Jacobson DR
    J Natl Cancer Inst; 1995 Jul; 87(14):1056-60. PubMed ID: 7616596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
    Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
    J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
    Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
    Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique.
    Behn M; Qun S; Pankow W; Havemann K; Schuermann M
    Clin Cancer Res; 1998 Feb; 4(2):361-71. PubMed ID: 9516924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.